Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...

Diabetes drug Ozempic will cost half-price for US patients paying cash - The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes pa ...

Faced with a shrinking buyer pool, sellers are beginning to feel pressure to cut prices, with 56% of homes selling below ...

Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to ...

New home listings picked up, and the overall for-sale inventory continued climbing, although the summer selling market has remained slow.

Who benefits? The reduced price applies to self-paying patients—those without insurance, or whose insurance doesn’t cover ...

Eli Lilly is significantly increasing the UK list price of its weight-loss and diabetes drug, Mounjaro, by up to 170%. This ...

Eli Lilly will raise the UK list price of its weight-loss treatment Mounjaro by up to 170%, it said on Thursday, amid a White ...

Eli Lilly & Co. is raising the list price for its obesity shot in the UK, as the pharma industry comes under pressure from US ...